Journal article
Eosinophilic inflammation in COPD: from an inflammatory marker to a treatable trait
- Abstract:
-
The heterogeneity of chronic obstructive pulmonary disease (COPD) creates many diagnostic, prognostic, treatment and management challenges, as the pathogenesis of COPD is highly complex and the underlying cellular and molecular mechanisms remain poorly understood. A reliable, easy-to-measure, clinically relevant biomarker would be invaluable for improving outcomes for patients. International and national guidance for COPD suggests using blood eosinophil counts as a biomarker to help estimate ...
Expand abstract
- Publication status:
- Published
- Peer review status:
- Peer reviewed
Actions
Access Document
- Files:
-
-
(Preview, Version of record, pdf, 519.1KB, Terms of use)
-
- Publisher copy:
- 10.1136/thoraxjnl-2020-215167
Authors
+ GlaxoSmithKline plc.
More from this funder
- Funder identifier:
- 10.13039/100004330
- Grant:
- Not applicable
- Publisher:
- BMJ Publishing Group
- Journal:
- Thorax More from this journal
- Volume:
- 76
- Issue:
- 2
- Pages:
- 188-195
- Publication date:
- 2020-10-29
- DOI:
- EISSN:
-
1468-3296
- ISSN:
-
0040-6376
- Language:
-
English
- Keywords:
- Pubs id:
-
1140990
- Local pid:
-
pubs:1140990
- Source identifiers:
-
W3095117711
- Deposit date:
-
2026-02-12
- ARK identifier:
This ORA record was generated from metadata provided by an external service. It has not been edited by the ORA Team.
Terms of use
- Copyright date:
- 2020
- Licence:
- Other
If you are the owner of this record, you can report an update to it here: Report update to this record